Beta blockers for heart failure - COPERNICUS reinforces their role

British Journal of Cardiology

Volumn 7, Issue 11, 2000, Pages 715-718

  McMurray, J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; SPIRONOLACTONE;

CLINICAL TRIAL; DISEASE COURSE; DOSE RESPONSE; HEART FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0033663746     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Prolongation of survival in congestive cardiomyopathy by beta receptor blockade
2. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
3. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure
4. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure - The PRECISE trial
5. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
6. Safety and efficacy of carvedilol in severe heart failure. The US Carvedilol Heart Failure Study Group
7. Beta-adrenergic blockers and survival in heart failure
8. Design of the cardiac insufficiency bisoprolol study II (CIBIS-II)
9. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
10. Rationale, design, and organization of the metoprolol CR/XL randomized intervention trial in heart failure (MERIT-HF)
11. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
12. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metroprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group
13. Reduced costs with bisoprolol treatment for heart failure: An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
14. Design of the Beta-blocker Evaluation Survival Trial (BEST)
15. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation study Investigators
16. Effect of amlodipine on morbidity and mortality in severe chronic heart failure
17. Major beta blocker mortality trials in chronic heart failure: A critical review